These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance]. Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908 [TBL] [Abstract][Full Text] [Related]
23. [Carcinomas of the distal bile duct]. Bahra M; Langrehr JM; Neuhaus P Chirurg; 2006 Apr; 77(4):335-40. PubMed ID: 16523255 [TBL] [Abstract][Full Text] [Related]
24. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus. Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991 [TBL] [Abstract][Full Text] [Related]
25. Invasion Depth Measured in Millimeters is a Predictor of Survival in Patients with Distal Bile Duct Cancer: Decision Tree Approach. Min KW; Kim DH; Son BK; Kim EK; Ahn SB; Kim SH; Jo YJ; Park YS; Seo J; Oh YH; Oh S; Kim HY; Kwon MJ; Min SK; Park HR; Choe JY; Jeon JY; Ha HI; Lee JW World J Surg; 2017 Jan; 41(1):232-240. PubMed ID: 27549598 [TBL] [Abstract][Full Text] [Related]
26. Validation of the Eighth American Joint Committee on Cancer Staging System for Distal Bile Duct Carcinoma. Jun SY; Sung YN; Lee JH; Park KM; Lee YJ; Hong SM Cancer Res Treat; 2019 Jan; 51(1):98-111. PubMed ID: 29510611 [TBL] [Abstract][Full Text] [Related]
27. Perineural invasion is a prognostic factor in intrahepatic cholangiocarcinoma. Shirai K; Ebata T; Oda K; Nishio H; Nagasaka T; Nimura Y; Nagino M World J Surg; 2008 Nov; 32(11):2395-402. PubMed ID: 18795245 [TBL] [Abstract][Full Text] [Related]
28. Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors? Ercolani G; Dazzi A; Giovinazzo F; Ruzzenente A; Bassi C; Guglielmi A; Scarpa A; D'Errico A; Pinna AD Eur J Surg Oncol; 2015 Sep; 41(9):1162-9. PubMed ID: 26095704 [TBL] [Abstract][Full Text] [Related]
29. Comparison of the Clinicopathologic Characteristics of Intraductal Papillary Neoplasm of the Bile Duct according to Morphological and Anatomical Classifications. Kim JR; Lee KB; Kwon W; Kim E; Kim SW; Jang JY J Korean Med Sci; 2018 Oct; 33(42):e266. PubMed ID: 30310366 [TBL] [Abstract][Full Text] [Related]
30. Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience. Ali SM; Clark CJ; Mounajjed T; Wu TT; Harmsen WS; Reid-Lombardo KM; Truty MJ; Kendrick ML; Farnell MB; Nagorney DM; Que FG HPB (Oxford); 2015 Mar; 17(3):244-50. PubMed ID: 25410716 [TBL] [Abstract][Full Text] [Related]
31. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. Klempnauer J; Ridder GJ; von Wasielewski R; Werner M; Weimann A; Pichlmayr R J Clin Oncol; 1997 Mar; 15(3):947-54. PubMed ID: 9060532 [TBL] [Abstract][Full Text] [Related]
32. Pancreatoduodenectomy for distal cholangiocarcinoma: prognostic impact of lymph node metastasis. Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Sueda T World J Surg; 2007 Feb; 31(2):337-42; discussion 343-4. PubMed ID: 17006609 [TBL] [Abstract][Full Text] [Related]
33. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ebata T; Nagino M; Kamiya J; Uesaka K; Nagasaka T; Nimura Y Ann Surg; 2003 Nov; 238(5):720-7. PubMed ID: 14578735 [TBL] [Abstract][Full Text] [Related]
34. Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas. Fujikura K; Fukumoto T; Ajiki T; Otani K; Kanzawa M; Akita M; Kido M; Ku Y; Itoh T; Zen Y Histopathology; 2016 Dec; 69(6):950-961. PubMed ID: 27410028 [TBL] [Abstract][Full Text] [Related]
35. Validation of the T category for distal cholangiocarcinoma: Measuring the depth of invasion is complex but correlates with survival. Park JY; Kim SY; Shin DH; Choi KU; Kim JY; Sol MY; Lee HJ; Hwang C; Ryu JH; Yang KH; Lee TB; Lee JH Ann Diagn Pathol; 2020 Jun; 46():151489. PubMed ID: 32169826 [TBL] [Abstract][Full Text] [Related]
36. Clinical impact of pancreatic invasion in T1-stage distal bile duct cancer and prognostic factors associated with long-term survival: A multicenter study. Jeon YW; Kang CM; Yoon YS; Kwon W; Han SS; Park Y; Kwak BJ; Lee W; Song KB; Lee JH; Kim SC; Shin SH; Hwang DW J Hepatobiliary Pancreat Sci; 2024 Sep; 31(9):658-670. PubMed ID: 39054662 [TBL] [Abstract][Full Text] [Related]
37. Survival analysis of intrahepatic cholangiocarcinoma after resection. Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987 [TBL] [Abstract][Full Text] [Related]
38. Carcinoma of the cystic duct remnant with direct colonic invasion. Noji T; Kondo S; Hirano S; Ambo Y; Tanaka E; Okushiba S; Katoh H Int J Gastrointest Cancer; 2003; 34(2-3):117-20. PubMed ID: 15361644 [TBL] [Abstract][Full Text] [Related]
39. Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. Uenishi T; Ariizumi S; Aoki T; Ebata T; Ohtsuka M; Tanaka E; Yoshida H; Imura S; Ueno M; Kokudo N; Nagino M; Hirano S; Kubo S; Unno M; Shimada M; Yamaue H; Yamamoto M; Miyazaki M; Takada T J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):499-508. PubMed ID: 24519806 [TBL] [Abstract][Full Text] [Related]
40. In favor of the Jarnagin-Blumgart classification. Ramacciato G; Nigri G; Ravaioli M; Del Gaudio M Ann Surg; 2009 Apr; 249(4):697-8; author reply 698-9. PubMed ID: 19300209 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]